HomeInsightsMarket Capitalization

Market Capitalization of Oxygenta Pharmaceutical Ltd

Market Capitalization of Oxygenta Pharmaceutical Ltd

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

43.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Oxygenta Pharmaceutical Ltd

NSE: OXYGENTAPHARMA

Market Cap

₹ 259.38 crore

Last updated on: Nov 22, 2024

Key Highlights

  • The Market Cap of Oxygenta Pharmaceutical Ltd is ₹ 259.38 crore as of 22 Nov 24 .
  • The Market Cap of Oxygenta Pharmaceutical Ltd changed from ₹ 34.15 crore on March 2022 to ₹ 97.07 crore on March 2024 . This represents a CAGR of 41.65% over 3 years.
  • The Latest Trading Price of Oxygenta Pharmaceutical Ltd is ₹ 73.1 as of 22 Nov 15:30 .

Historical Market Cap of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Company Fundamentals for Oxygenta Pharmaceutical Ltd

No data available

Image

Oxygenta Pharmaceutical Ltd

NSE: OXYGENTAPHARMA

Share Price

₹ 73.1

2.25 (3.18%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Oxygenta Pharmaceutical Ltd

1M

1Y

3Y

5Y

Monitoring Oxygenta Pharmaceutical Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202473.1
21 Nov 202470.85
19 Nov 202474.22
18 Nov 202477.87
14 Nov 202481.96
13 Nov 202483.63
12 Nov 202485.33
11 Nov 202487.07
08 Nov 202488.84
07 Nov 202490.65

SWOT Analysis Of Oxygenta Pharmaceutical Ltd

Strength

0

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Oxygenta Pharmaceutical Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Oxygenta Pharmaceutical Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Oxygenta Pharmaceutical Ltd

No data available

No data available

Historical P/E Ratio of Oxygenta Pharmaceutical Ltd

No data available

* All values are in %

Historical Revenue of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Historical EBITDA of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Historical Net Profit of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Oxygenta Pharmaceutical Ltd

  • Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
  • Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 2021-22. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.
  • The Company is doing contract manufacturing work for APL and also having its own production.
  • The Company is engaged in manufacture of bulk drugs.
  • It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.

Oxygenta Pharmaceutical Ltd News Hub

News

Oxygenta Pharmaceutical announces board meeting date

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14...

Read more

11 Nov 202411:06

News

Oxygenta Pharmaceutical schedules AGM

Oxygenta Pharmaceutical announced that the 31th Annual General Meeting (AGM) of the compan...

Read more

18 Sep 202410:58

News

Oxygenta Pharmaceutical to discuss results

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14...

Read more

12 Aug 202414:50

News

Oxygenta Pharmaceutical to announce Quarterly Result

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 30...

Read more

28 May 202415:31

News

Oxygenta Pharmaceutical EGM scheduled

Oxygenta Pharmaceutical announced that an Extra Ordinary General Meeting (EGM) of the Comp...

Read more

09 Apr 202417:34

News

Oxygenta Pharmaceutical to convene board meeting

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 8 ...

Read more

04 Apr 202409:26

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Oxygenta Pharmaceutical Ltd Market Cap

What is the market cap of Oxygenta Pharmaceutical Ltd?

As of November 23, 2024, Oxygenta Pharmaceutical Ltd has a market capitalization of ₹259.38, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Oxygenta Pharmaceutical Ltd's market capitalization?

Oxygenta Pharmaceutical Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Oxygenta Pharmaceutical Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Oxygenta Pharmaceutical Ltd's market capitalization change?

Oxygenta Pharmaceutical Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*